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Abstract: A stereoselective direct 
transformation of N-
(propargylic)hydroxylamines into cis-2-
acylaziridines was realized by the 
combined use of AgBF4 and CuCl. 
Copper salts were confirmed to 
promote the transformation of the 
intermediary 4-isoxazolines to 2-
acylaziridines. Both 3-aryl and 3-alkyl 
substituted 2-acylaziridines could be 
prepared by this method. Furthermore, 
subsequent 1,3-dipolar cycloaddition of 
azomethine ylides generated in situ 
from the intermediary 2-acylaziridines 
with maleimides was achieved by one-
pot procedure to afford the 
corresponding 2-acylpyrrolidines 
consisting of an octahydropyrrolo[3,4-
c]pyrrole skeleton stereoselectively. 
Keywords: 2-acylaziridine • 2-
acylpyrrolidine • 4-isoxazoline • 
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Introduction 
2-Acylaziridines are versatile synthetic intermediates for a wide 
range of important nitrogen-containing chemicals, for example via 
ring-opening reactions,[1] and some of them have biological 
activities.[2] General procedure to prepare 2-acylaziridines includes 
metal catalyzed addition of nitrene to alkenes,[3] metal catalyzed 
carbene addition to imine functions,[4] Micheal addition-elimination 
of hydroxylamine and hydrazine derivatives to enones,[5] ring-
closure of 2-azido-3-hydroxy ketones,[6] and nucleophilic reaction of 
amines to α,β-dibromoketones.[7] Although trans-2-acylaziridines 
could be readily prepared, stereoselective synthesis of cis-2-
acylaziridines is rather difficult. Only a few methods for preparation 
of cis-3-alkyl substituted 2-acylaziridines were reported.[4a,b,d] 
Baldwin rearrangement of 4-isoxazolines was known to afford 2-
acylaziridines, however, the reaction conditions were drastic and the 
diastereoselectivity was not always good.[8] Although cobalt-
mediated rearrangement of 4-isoxazolines also gave the 
corresponding 2-acylaziridines, stereoselectivity was not so high.[8i] 
Recently, microwave-assisted rearrangement was reported, however, 
the methods was limited to 3-aryl substituted acylaziridines.[8m] 
Recently, we have reported a one-pot reaction consisting of an 
enantioselective nucleophilic addition of alkynylzinc reagents to 
nitrones and a subsequent cyclization to give the corresponding 4-
isoxazolines with high enantioselectivity.[9] In order to prepare 4-
isoxazolines more efficiently, the cyclization of N-
(propargylic)hydroxylamines to 4-isoxazolines was investigated in 
the presence of a metal salt, and AgBF4 was found to be a catalyst of 
choice for the cyclization.[10] During the investigation of the metal 
catalyzed ring closure of N-(propargylic)hydroxylamines, cis-2-
acylaziridines were found to be produced diastereoselectively in the 
presence of a copper salt at rt. Herein, we wish to report the details 
about one-pot preparation of 2-acylaziridines from N-
(propargylic)hydroxylamines via ring closure to 4-isoxazolines and 
the successive Baldwin rearrangement in the presence of AgBF4 and 
a copper salt.[11] Furthermore, one-pot stereoselective synthesis of 2-
acylpyrrolidines via 1,3-dipolar cylcloaddition of azomethine ylides 
generated from the 2-acylaziridines is also described.   
Results and Discussion 
The cyclization of N-benzyl-N-(1,3-diphenylprop-2-
ynyl)hydroxylamine (1a) was examined in the presence of various 
kinds of metal salts without an amine, and it was found that AgBF4 
was a good catalyst for cyclization to 4-isoxazolines.[10] During the 
survey of metal salts, it was found that not only 4-isoxazoline 2a but 
also a cis-2-acylaziridine 3a[8i,12] was produced with complete 
diastereoselectivity when CuCl was used in CH2Cl2 at rt (Table 1, 
Entry 1). Then, direct transformation of 1a to 2-acylaziridine 3a was 
intensively investigated and the results were summarized in Table 1. 
The reaction by the use of 1.0 equiv of CuCl2 or CuI was messy 
and the 2-acylaziridine 3a was not obtained (Entries 2 and 3). The 
use of cationic copper salts afforded the cis-2-acylaziridine 3a as a 
major product (Entries 4–7), however, the chemical yield was not 
high. By monitoring the reaction using TLC, it was observed that 
the 4-isoxazoline was once produced and gradually consumed. In 
order to promote the cyclization step to 4-isoxazoline, N-
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(propargylic)hydroxylamine was firstly treated with 0.1 equiv 
AgBF4 for 7 h and then CuCl was added to the reaction mixture: 
The chemical yield of 3a was improved (Entry 8). The treatment 
with AgBF4 together with CuCl further increased the yield of 3a 
(Entry 9). By the use of 0.2 equiv of AgBF4 and 1.0 equiv of CuCl, 
the reaction proceeded rather smoothly to afford 3a in more than 
80% yield (Entries 10 and 11). Solvent effect was examined in the 
reaction using 0.2 equiv of AgBF4 and 1.0 equiv of CuCl, and 
CH2Cl2 was found to be best among the examined solvents (Entries 
11–16). Although combination of 0.2 equiv of AgBF4 and 1.0 equiv 
of several cationic copper salts were examined, the reactions were 
not so clean and resulted in decrease of the chemical yields of 3a 
(Entries 17–20). 
In order to explore the possibilities reducing the amount of 
copper salt, the reaction using 0.2 equiv of CuCl with 0.2 equiv of 
AgBF4 was carried out: The transformation proceeded a little 
sluggishly to afford 3a, but still in comparably good yield (Entries 
21 and 22). In the present one-pot reaction, the active copper species 
was presumed to be CuBF4 accompanied with generation of AgCl. 
Then the reaction in the presence of only 0.2 equiv of 
CuBF4(CH3CN)2 was again examined to give the cis-2-acylaziridine 
3a in good yield (Entry 23), although the use of 1.0 equiv of 
CuBF4(CH3CN)4 made the reaction rather complicated (Entry 6). 
Further addition of AgCl slightly decreased the yield (Entry 24). 
The use of 0.2 equiv of CuOTf(C6H6)0.5 was also effective to give 
3a in good yield (Entry 25). Consequently, the combined use of 0.2 
equiv of AgBF4 and 1.0 equiv of CuCl was the best for the 
sequential cyclization and Baldwin rearrangement. 
 














solvent, rt, t h
 
Entry n1 / equiv CuXm n2 / equiv solvent t / h 2a / % 3a / % 
  1 0 CuCl 1.0 CH2Cl2 41 16     2[a] 
  2 0 CuCl2 1.0 CH2Cl2 44 -- -- 
  3 0 CuI 1.0 CH2Cl2 44 --   --[b] 
  4 0 CuOTf(C6H6)0.5 1.0 CH2Cl2 17 23 58 
  5 0 Cu(OTf)2 1.0 CH2Cl2 48 -- 45 
  6 0 CuBF4(CH3CN)4 1.0 CH2Cl2   7 -- 45 
  7 0 Cu(BF4)2 1.0 CH2Cl2 25 -- 48 
     8[c] 0.1 CuCl 1.0 CH2Cl2 41 24 53 
  9 0.1 CuCl 1.0 CH2Cl2   8 32 61 
10 0.2 CuCl 1.0 CH2Cl2   8 13 84 
11 0.2 CuCl 1.0 CH2Cl2 20   4 88 
12 0.2 CuCl 1.0 MeCN 20 24   --[a] 
13 0.2 CuCl 1.0 MeOH 20 12 21 
14 0.2 CuCl 1.0 THF 20 23 47 
15 0.2 CuCl 1.0 Et2O 20 22     6[a] 
16 0.2 CuCl 1.0 toluene 20 28    13[a] 
17 0.2 CuOTf(C6H6)0.5 1.0 CH2Cl2   7 -- 35 
18 0.2 Cu(OTf)2 1.0 CH2Cl2   8 -- 13 
19 0.2 CuBF4(CH3CN)4 1.0 CH2Cl2   8 -- 42 
20 0.2 Cu(BF4)2 1.0 CH2Cl2   8 10 42 
21 0.2 CuCl 0.2 CH2Cl2   8 10 58 
22 0.2 CuCl 0.2 CH2Cl2 23 -- 82 
23 0 CuBF4(CH3CN)4 0.2 CH2Cl2 23 -- 74 
24 0.2[d] CuBF4(CH3CN)4 0.2 CH2Cl2 23 -- 65 
25 0 CuOTf(C6H6)0.5 0.2 CH2Cl2 41 -- 78 
[a] The hydroxylamine 1a was recovered in 69% (Entry 1), 32% (Entry 12), 65% (Entry 
15), and 7% (Entry 16) yields, respectively. [b] Most of the hydroxylamine 1a was 
recovered. [c] The hydroxylamine 1a was firstly treated with AgBF4 for 7 h, and then 
CuCl was added to the resulting reaction mixture. [d] 0.2 Equiv of AgCl was used 
instead of AgBF4. 
 
Toward the rearrangement from 4-isoxazoline to 2-acylaziridine, 
evaluation of copper salts was separately performed, that is, the 4-
isoxazoline 2a was treated with copper salts as shown in the Table 2. 
Although the reaction was rather sluggish when only CuCl was used, 
addition of AgBF4 again promoted the rearrangement (Entries 1 and 
2). Cationic Cu(I) salts, especially CuOTf(C6H6)0.5, were found to be 
effective as a promoter for this rearrangement (Entries 3 and 5), 
whereas Cu(II) salts were not effective (Entries 4 and 6). 
 








CH2Cl2, rt, t h
 
Entry CuXm t / h Yield / % 
1 CuCl 41    23[a] 
   2[b] CuCl 18 89 
3 CuOTf(C6H6)0.5   4 81 
4 Cu(OTf)2 41   3 
5 CuBF4(CH3CN)4 22 71 
6 Cu(BF4)2 41 45 
[a] The 4-isoxazoline 2a was recovered in 68% yield. [b] In addition to CuCl, 0.2 equiv 
of AgBF4 was also added to the reaction. 
 
The one-pot cyclization-rearrangement was applied to several N-
(propargylic)hydroxylamines 1 bearing aromatic and/or aliphatic 
substituents by the treatment with AgBF4 (0.2 equiv) and CuCl (1.0 
equiv). As listed in Table 3, the corresponding cis-acylaziridines 3 
were produced stereoselectively.[12] A cis-2-heptanoyl-3-
phenylaziridine 3b was obtained in reasonable chemical yield (Entry 
2). In the case of 2-pivaloylaziridine 3c, a small amount of trans-
isomer was furnished (Entry 3). Although transformation of propyl-
substituted hydroxylamine 1d was not so clean and a small amount 
of the corresponding trans-isomer and a dehydrated imine 4d were 
formed, cis-2-benzoyl-3-propylaziridine 3d was predominantly 
produced (Entry 4). In the case of cyclohexyl-substituted N-
(propargylic)hydroxylamine 1e, increase of the amount of AgBF4 
could improve the chemical yield (Entries 5 and 6). The reaction of 
a hydroxylamine 1f, in which both R1 and R2 were alkyl groups, 
afforded cis-2-acylaziridine 3f stereoselectively (Entry 7). 
 














CH2Cl2, rt, t h
 
Entry R1 R2  t / h 2a / % 3a / % 
1 Ph Ph a 20   4 88 
2 Ph nHex b 27 -- 63 
3 Ph tBu c 24 --    72[a] 
4 nPr Ph d 41 --      49[a,b] 
5 cHex Ph e 25 14 64 
   6[c]    24   7 76 
7 Me nHex f 23 -- 58 
[a] The corresponding trans-isomer of 3 was obtained in 6% (Entry 3) and 10% (Entry 
4) yields, respectively. [b] An imine, 1-phenyl-N-(1-phenylhex-1-yn-3-






In the case of Co2(CO)8 (0.5 equiv) mediated rearrangement of 
4-isoxazoline, a radical pathway was proposed to give 2.8/1 mixture 
of cis/trans-2-acylaziridines starting from 1a.[8i] When 1a was 
treated with 1.0 equiv of CuOTf(C6H6)0.5 under a similar conditions 
(in ClCH2CH2Cl at 80 °C for 0.5 h), 3a was obtained in 80% yield 
and the diastereoselectivity was still high (3a/trans-isomer = 20/1, 
determined by 1H NMR spectrum of the crude products), different 
from the result of the reaction catalyzed by Co2(CO)8. Furthermore, 
addition of galvinoxyl free radical did not affect the reaction from 
 3 
2a to 3a (according to Entry 3 in Table 2) as a radical inhibitor. 
These facts might suggest that a radical pathway might be ruled out. 
Although the precise reaction mechanism of the present 
rearrangement is not yet clear, [1,3]-sigmatropic rearrangement 
proposed for original Baldwin rearrangement without metal salts is a 
probable pathway to afford the cis-2-acylaziridine (Figure 1).[8c,d,f] 
The reaction might be activated by coordination of nitrogen to 











Figure 1. [1,3]-Sigmatropic rearrangement proposed for the present transformation 
 
2-Acylaziridines are well-known to generate azomethine ylides 
via thermal ring-opening, which proceeds through a conrotatory C–
C bond-breaking process according to the Woodward–Hoffmann 
rules. Following 1,3-dioplar cycloaddition of the generated 
azomethine ylides with electron-deficient olefins afforded 2-
acylpyrrolidine skeletons,[13,14] some of which were bioactive.[15] For 
example, the cycloaddition of azomethine ylides generated from cis- 
and/or trans-2-benzoylaziridines with N-phenylmaleinimde gave a 
diastereomeric mixture of pyrrolidines depends on the reaction 
conditions.[14d,e] However, cis-2-acylaziridines were not so easy to 
be prepared and related cycloaddition of azomethine ylides derived 
from 2-acylaziridines with various substituents including aliphatic 
groups at C3 position was scarcely reported. Now, we could prepare 
2-acylaziridines possessing aromatic and/or aliphatic substitutents in 
a cis-selective manner. Therefore, we investigated 1,3-dipolar 
cycloaddition of azomethine ylides generated in situ from the 2-
acylaziridines via one-pot procedure starting from N-
(propargylic)hydroxylamines 1. 
After treatment of N-(propargylic)hydroxylamines 1a with 0.2 
equiv of AgBF4 and 1.0 equiv of CuCl for 24 h at rt in CH2Cl2, N-
methylmaleimide (5A) was added to the reaction mixture. When the 
reaction was carried out at rt, the desired product was not obtained. 
However, the expected 1,3-dipolar cycloaddition proceeded at 75 °C 
in ClCH2CH2Cl, after exchanging the solvent from CH2Cl2, to give a 
2-acylpyrrolidine 6aA consisting of an octahydropyrrolo[3,4-
c]pyrrole skeleton diastereoselectively in 33% yield (Table 4, Entry 
1). Cycloaddition to N-benzylmaleimide (5B) afforded the 
corresponding cycloadduct 6aB in a similar chemical yield (Entry 2). 
Due to easy handling of N-benzylmaleimide (5B) and its product 
6aB especially for their relatively high solubility, 1,3-dipolar 
cycloaddition was further examined using 5B. When the reaction 
temperature was increased, the chemical yield was improved (Entry 
3). The cycloadduct 6aB was obtained in 60% yield when 
cycloaddition was carried out at 145 °C in xylene (Entry 4). When 
the reaction was performed under more condensed conditions, the 
chemical yield was further improved up to 85% yield (Entry 5).   
One-pot synthesis of substituted pyrrolidines was then 
investigated starting from N-(propargylic)hydroxylamines 1 
possessing not only aromatic but also aliphatic substituents. Phenyl-
substituted pyrrolidines 6bB and 6cB (R1 = Ph) were obtained in ca 
60% yields with complete diastereoselectivity (Entries 6 and 7). It 
was revealed that 1,3-dipolar cycloaddition of azomethine ylides via 
2-acylaziridines 3d–f bearing an aliphatic substituent at C3 position 
(R1 = alkyl) afforded the corresponding pyrrolidines 
stereoselectively although total chemical yields were not good 
enough (Entries 8–11). In the case of 5-cylohexyl-substituted 
pyrrolidines 6eA and 6eB, chemical yields were still over 50% 
yields after 3 step-reaction consisting of ring-closure, Baldwin 
rearrangement, and 1,3-dipolar cycloaddition (Entries 9 and 10). 
 





OHBn AgBF4 (0.2 equiv)
CuCl (1.0 equiv)
1
















Entry R1 R2 R t1 / h solvent T / °C t2 / h 6 Yield / % 
 1 Ph Ph Me 24 ClCH2CH2Cl[a]   75 24 6aA 33 
 2 Ph Ph Bn 24 ClCH2CH2Cl[a]   75 24 6aB 32 
 3    24 toluene[a] 110   6  53 
 4    27 xylene[a] 145   1  60 
 5    24 xylene[b] 145   2  85 
 6 Ph nHex Bn 31 xylene[b] 145   3 6bB 56 
 7 Ph tBu Bn 31 xylene[b] 145   1 6cB 66 
 8 nPr Ph Bn 48 xylene[b] 145   2 6dB 39 
    9[c] cHex Ph Me 27 xylene[b] 145   3 6eA 52 
  10[c] cHex Ph Bn 27 xylene[b] 145   3 6eB 53 
11 Me nHex Bn 24 xylene[b] 145     1.5 6fB 27 
[a] Concentration was 0.06 mmol mL–1. [b] Concentration was 0.25 mmol mL–1.  











































Figure 3. X-ray structure of 6eA 
 
Relative stereochemistry of the product 6aB and 6eA was 
determined to be 3aR*,4R*,6R*,6aS* by X-ray crystallographic 
analyses of their single crystals (Figures 2 and 3). The 
stereochemistry of other cycloadducts was tentatively assigned to be 
also 3aR*,4R*,6R*,6aS*, since the coupling constants J3a–4 and J6–6a 
between the methine protons in their 1H NMR spectra were in 
accordance with those of 6aB and 6eA, the stereochemistry of 
which was determined by X-ray crystallography. Based on this 
assignment, 1,3-dipolar cycloaddition was considered to proceed via 
exo-mode with S-shaped azomethine ylide 7 and/or endo-mode with 
S-shaped azomethine ylide 8 regardless of R1, whether it is an 
aromatic or aliphatic substituent (Scheme 1).[16] In the case of 
pyrrolidines 6cB and 6dB, the products were isolated as single 
diastereomers although the intermediary cis-2-acylaziridines might 
be contaminated with their trans-isomers as observed in Table 3 
(Entries 3 and 4). We confirmed that 1,3-dipolar cycloaddition of 
 4 
the isolated trans-isomer of 3c with 5B gave 6cB stereoselectively at 
145 °C in xylene in 84% yield (eq. 1).[17] These results suggested 
existence of the equilibrium between W-dipole 9, which might be 
favorable than U-dipole,[18] and S-dipole 7 and/or 8 under high 
temperature even in the case of 3-alkyl substituted 2-acylaziridine 
3d.[19] Therefore, the trans-2-acylaziridine also afforded 6 via 1,3-









































































xylene 145 °C, 1.5 h
  
Conclusion 
As described above, a direct transformation of N-
(propargylic)hydroxylamines into cis-2-acylaziridines has been 
developed. Furthermore, one-pot stereoselective preparation of 2-
acylpyrrolidine consisting of an octahydropyrrolo[3,4-c]pyrrole 
skeleton was achieved via 1,3-dipolar cycloaddition of azomethine 
ylides, generated in situ by thermal ring-opening of the intermediary 
2-acylaziridines, in the presence of maleimides. The present 
methods would be quite useful for the synthesis of a wide range of 
nitrogen containing biologically active compounds because cis-2-
acylaziridines and 2-acylpyrrolidines are versatile synthons for such 
chemicals.  
Experimental Section 
General Remarks: The 1H NMR spectra were recorded on a JEOL ECS 400 NMR (400 
MHz) spectrometer in CDCl3 and the chemical shifts were determined in the δ-scale 
relative to TMS (δ = 0 ppm) as an internal standard.  The 13C NMR spectra were 
measured on a JEOL ECS 400 NMR (100 MHz) spectrometer in CDCl3 and the 
chemical shifts were determined in the δ-scale relative to CDCl3 (δ = 77.0 ppm) as an 
internal standard. The IR spectra were performed on a JASCO FT/IR-230 spectrometer. 
All measurements for X-ray crystallographic analyses were made on a Rigaku/MSC 
Mercury diffractometer with graphite monochromated Mo-Kα radiation. Elemental 
analyses were carried out on a Yanaco CHN Corder MT-5 elemental analyzer. The MS 
spectra were recorded with JEOL JMS-SX102A and JMS-700 mass spectrometers. All 
solvents were distilled and stored over drying agents. Merck silica gel 60 PF254 (Art. 
7749) and Cica silica gel 60N spherical neutral (37563-84) were used for thin-layer 
chromatography (TLC) and flash column chromatography, respectively. All of the 
melting points were determined with a micro melting apparatus (Yanagimoto-
Seisakusho) and are uncorrected. 
Representative procedure of direct transformation of N-
(propargylic)hydroxylamine 1a to 2-acylaziridine 3a (Table 3, Entry 1): A mixture 
of N-(propargylic)hydroxylamine 1a (219 mg, 0.7 mmol), AgBF4 (27 mg, 0.14 mmol) 
and CuCl (69 mg, 0.7 mmol) in CH2Cl2 (20 mL) was stirred at rt under an argon 
atmosphere. After 20 h, the mixture was filtered through a pad of Celite and the solvent 
was removed under reduced pressure. The residue was purified by preparative TLC 
(hexane/AcOEt = 5/1) to give cis-2-acylaziridine 3a (193 mg, 88% yield) and 4-
isoxazoline 2a[20] (9 mg, 4% yield).  
In a similar manner, 2-acylaziridines 3b–3f were prepared from the corresponding N-
(propargylic)hydroxylamines 1b–1f, respectively.  
 [(2R*,3R*)-1-Benzyl-3-phenylaziridin-2-yl](phenyl)methanone (3a):[8i] Rf = 0.35 
(hexane/AcOEt = 5/1); a solid; m.p. 94–96 °C (from EtOH/hexane); 1H NMR δ 3.22 (d, 
1H, J = 6.9 Hz), 3.30 (d, 1H, J = 6.9 Hz), 3.71 (d, 1H, J = 14.0 Hz), 3.93 (d, 1H, J = 
14.0 Hz), 7.01–7.40 (m, 13 H), 7.77 (d, 2H, J = 6.4 Hz); 13C NMR δ 49.6, 51.0, 63.5, 
127.0, 127.2, 127.4, 127.7, 127.8, 127.9, 128.2, 132.8, 134.8, 136.7, 137.7, 192.9; IR 
(KBr) 3027, 1681, 1495, 1449, 1355, 1223, 1056, 935, 747, 737, 707, 696 cm–1. 
1-[(2R*,3R*)-1-Benzyl-3-phenylaziridin-2-yl]heptan-1-one (3b): Rf = 0.45 
(hexane/AcOEt = 5/1); an oil; 1H NMR δ 0.80 (t, 3H, J = 7.4 Hz), 0.88–1.30 (m, 8H), 
1.88 (ddd, 1H, J = 17.4, 8.2, 6.4 Hz), 2.20 (ddd, 1H, J = 17.4, 8.2, 6.4 Hz), 2.64 (d, 1H, 
J = 7.0 Hz), 3.14 (d, 1H, J = 7.0 Hz), 3.69 (d, 1H, J = 13.8 Hz), 3.78 (d, 1H, J = 13.8 
Hz), 7.18–7.43 (m, 10H); 13C NMR δ 14.0, 22.3, 22.8, 28.5, 31.4, 40.7, 48.6, 52.4, 64.0, 
127.36, 127.43, 127.8, 128.10, 128.14, 128.4, 135.3 138.0, 207.4; IR (neat) 3062, 3031, 
2928, 2857, 1699, 1604, 1496, 1454, 1376, 1204, 1067, 1029, 738, 699 cm–1; HRMS 
(EI+) (M+), Found: m/z 321.2087; Calcd for C22H27NO: 321.2093. 
1-[(2R*,3R*)-1-Benzyl-3-phenylaziridin-2-yl]-2,2-dimethylpropan-1-one (3c): Rf = 0.45 
(hexane/AcOEt = 5/1); a solid; m.p. 85–88 °C (from EtOH/hexane); 1H NMR δ 0.96 (s, 
9H), 3.05 (d, 1H, J = 6.8 Hz), 3.12 (d, 1H, J = 6.8 Hz), 3.67 (d, 1H, J = 14.0 Hz), 3.94 
(d, 1H, J = 14.0 Hz), 7.19–7.41 (m, 10H); 13C NMR δ 25.7, 43.2, 49.4, 50.0, 63.4, 126.8, 
127.1, 127.4, 127.5, 128.1, 134,9, 137.7, 206.6; IR (KBr) 3027, 2973, 1703, 1604, 1495, 
1455, 1378, 1312, 1265, 1091, 1027, 840, 758, 732 cm-1; Found: C, 81.81; H, 7.79; N, 
4.79%; Calcd for C20H23NO: C, 81.87; H, 7.90; N, 4.77%.  
1-[(2S*,3R*)-1-Benzyl-3-phenylaziridin-2-yl]-2,2-dimethylpropan-1-one (trans-isomer 
of 3c): Rf = 0.50 (hexane/AcOEt = 5/1); an oil; 1H NMR δ 1.04 (s, 9H), 3.15 (d, 1H, J = 
2.5 Hz), 3.37 (d, 1H, J = 2.5 Hz), 3.93 (d, 1H, J = 13.8 Hz), 4.20 (d, 1H, J = 13.8 Hz), 
7.19–7.41 (m, 10H); 13C NMR δ 25.7, 44.6, 45.9, 49.7, 54.0, 126.3, 126.9, 128.2, 128.4, 
128.5, 138.9, 139.3, 210.2; IR (neat) 3038, 2966, 1683, 1541, 1507, 1457, 1395, 1362, 
1073, 752, 698 cm–1; HRMS (EI+) (M+), Found: m/z 293.1774; Calcd for C20H23NO: 
293.1780.  
[(2R*,3R*)-1-Benzyl-3-propylaziridin-2-yl](phenyl)methanone (3d): Rf = 0.40 
(hexane/AcOEt = 4/1); an oil; 1H NMR δ 0.80 (t, 3H, J = 7.3 Hz), 1.18–1.52 (m, 4H), 
2.21 (q, 1H, J = 6.4 Hz), 3.08 (d, 1H, J = 6.9 Hz), 3.61 (d, 1H, J = 13.7 Hz), 3.77 (d, 1H, 
J = 13.7 Hz), 7.22–7.56 (m, 8H), 8.00 (d, 2H, J = 8.2 Hz); 13C NMR δ 13.7, 20.6, 29.6, 
47.4, 48.9, 64.1, 127.1, 128.0, 128.1, 128.3, 128.5, 133.1, 137.3, 137.9, 195.2; IR (neat) 
3059, 2954, 2869, 1673, 1596, 1578, 1496, 1449, 1389, 1361, 1228, 1067, 1020, 930, 
737, 700, 661 cm-1; HRMS (EI+) (M+), Found: m/z 279.1621; Calcd for C19H21NO: 
279.1623.  
[(2S*,3R*)-1-Benzyl-3-propylaziridin-2-yl](phenyl)methanone (trans-isomer of 3d): Rf 
= 0.45 (hexane/AcOEt = 4/1); an oil; NMR showed the presence of two isomers (ratio = 
3.5/1), which might be a sort of diastereomers in equilibrium as depicted below.21 Major 
isomer: 1H NMR δ 0.86 (t, 3H, J = 7.3 Hz), 1.30–1.37 (m, 2H), 1.48–1.56 (m, 2H), 2.59 
(dt, 1H, J = 2.7, 6.0 Hz), 3.40 (d, 1H, J = 2.7 Hz), 3.78 (d, 1H, J = 13.3 Hz), 3.86 (d, 1H, 
J = 13.3 Hz), 7.18–7.59 (m, 8H), 7.92–7.95 (m, 2H); 13C NMR δ 13.8, 20.4, 34.9, 44.2, 
48.1, 55.3, 126.9, 128.2, 128.3, 128.5, 128.6, 133.1, 138.4, 139.1, 196.1; Minor isomer: 
1H NMR δ 0.99 (t, 3H, J = 7.3 Hz), 1.47–1.91 (m, 4H), 2.66 (dt, 1H, J = 2.7, 7.4 Hz), 
2.87 (d, 1H, J = 2.7 Hz), 3.72 (d, 1H, J = 14.2 Hz), 4.10 (d, 1H, J = 14.2 Hz), 7.18–7.59 
(m, 8H), 7.92–7.95 (m, 2H); 13C NMR δ 14.0, 21.5, 28.0, 47.6, 48.3, 127.6. 128.1, 
128.4, 128.5, 133.0, 138.9, 196.6 (Three signals might be overlaped with those of major 
isomer); IR (neat) 3061, 2959, 2929, 2871, 1667, 1538, 1449, 1379, 1265, 1070, 1026, 















1-Phenyl-N-(1-phenylhex-1-yn-3-ylidene)methanamine (4d): Rf = 0.20 (hexane/AcOEt 
= 5/1); a solid; m.p. 77–78 °C (from AcOEt/hexane); 1H NMR δ 0.93 (t, 3H, J = 7.3 Hz), 
1.57–1.68 (m, 2H), 2.55 (t, 2H, J = 7.8 Hz), 5.31 (s, 2H), 7.23–7.31 (m, 6 H), 7.37–7.40 
(m, 2H), 7.44 (d, 2H, J = 7.8 Hz); 13C NMR δ 13.7, 18.8, 32.4, 66.6, 82.9, 104.2, 121.5, 
128.3, 128.5, 128.6, 129.3, 131.0, 133.9, 134.0; IR (KBr) 3058, 2955, 2870, 1517, 1485, 
1438, 1303, 1250, 1176, 1164, 935, 759 cm–1; HRMS (FAB+) (M+ + H), Found: m/z 
262.1592; Calcd for C19H20N : 262.1596. 
[(2R*,3R*)-1-Benzyl-3-cyclohexylaziridin-2-yl](phenyl)methanone (3e): Rf = 0.40 
(hexane/AcOEt = 5/1); a solid; m.p. 113–115 °C (from hexane/EtOH); 1H NMR δ 0.92–
1.26 (m, 6H), 1.40–1.76 (m, 5H), 1.96 (dd, 1H, J = 8.7, 6.9 Hz), 3.10 (d, 1H, J = 6.9 
Hz), 3.60 (d, 1H, J = 13.7  Hz), 3.73 (d, 1H, J = 13.7 Hz), 7.23–7.58 (m, 8H), 8.01 (d, 
2H, J = 7.3 Hz); 13C NMR δ 25.27, 25.29, 26.0, 30.2, 31.2, 35.5, 47.3, 55.1, 64.5, 127.1, 
128.0, 128.17, 128.19, 128.4, 132.9, 137.3, 137.8, 195.0; IR (KBr) 3031, 2924, 2849, 
1683, 1598, 1448, 1225, 1049, 1023, 915, 738, 688 cm–1; Found: C, 82.72; H, 7.89; N, 
4.38%; Calcd for C22H25NO: C, 82.41; H, 7.94; N, 4.42%.  
 5 
1-[(2R*,3R*)-1-Benzyl-3-methylaziridin-2-yl]heptan-1-one (3f): Rf = 0.45 
(hexane/AcOEt = 4/1); an oil; 1H NMR δ 0.86 (t, 3H, J = 5.5 Hz), 1.19 (d, 3H, J = 5.5 
Hz), 1.19–1.30 (m, 6H), 1.46–1.56 (m, 2H), 2.05 (dq, 1H, J = 6.9, 5.5 Hz), 2.32 (d, 1H, 
J = 6.9 Hz), 2.38–2.53 (m, 2H), 3.43 (d, 1H, J = 13.7 Hz), 3.69 (d, 1H, J = 13.7 Hz), 
7.21–7.36 (m, 5H); 13C NMR δ 13.3, 14.0, 22.4, 23.5, 28.9, 31.5, 42.3, 43.4, 49.1, 63.9, 
127.1, 127.8, 128.3, 138.2, 207.8; IR (neat) 3030, 2956, 2928, 2858, 1699, 1496, 1454, 
1413, 1354, 1142, 1121, 1073, 1030, 733, 698 cm–1; HRMS (EI+) (M+), Found: m/z 
259.1937; Calcd for C17H25NO : 259.1936.  
Representative procedure of one-pot synthesis of 2-acylpyrrolidine 6aB starting 
from N-(propargylic)hydroxylamine 1a (Table 4, Entry 5): A mixture of N-
(propargylic)hydroxylamine 1a (157 mg, 0.5 mmol), AgBF4 (19 mg, 0.1 mmol) and 
CuCl (50 mg, 0.5 mmol) in CH2Cl2 (5 mL) was stirred at rt under an argon atmosphere. 
After 24 h, N-benzylmaleimide (5B) (112 mg, 0.6 mmol) in xylene (2 mL) was added to 
the reaction mixture and CH2Cl2 was evaporated under the reduced pressure. The 
resulting mixture in xylene was heated at 145 °C for 2 h and cooled to rt. The insoluble 
substance was filtered off through a pad of Celite and the solvent was removed under 
reduced pressure. The residue was purified by preparative TLC (hexane/Et2O = 1/1) to 
give 6aB (215 mg, 85% yield).  
In a similar manner, other 2-acylpyrrolidines 6aA, 6eA, and 6bB–6fB were prepared 
from the corresponding N-(propargylic)hydroxylamines 1a–1f, respectively.  
(3aR*,4R*,6R*,6aS*)-4-Benzoyl-5-benzyl-2-methyl-6-phenyltetrahydropyrrolo[3,4-
c]pyrrole-1,3(2H,3aH)-dione (6aA): Rf = 0.30 (hexane/Et2O = 1/1); a solid; m.p. 164–
165 °C (from AcOEt/hexane); 1H NMR δ 2.94 (s, 3H), 3.24 (d, 1H, J = 7.8 Hz), 3.63 (d, 
1H, J = 13.7 Hz), 3.70 (dd, 1H, J = 9.6, 7.8 Hz), 3.77 (d, 1H, J = 13.7 Hz), 5.15 (d, 1H, 
J = 9.6 Hz), 5.24 (s, 1H), 7.04–7.12 (m, 2H), 7.19–7.22 (m, 3H), 7.29–7.41 (m, 7H), 
7.56 (t, 1H, J = 7.3 Hz), 7.80 (dd, 2H, J = 8.3, 0.9 Hz); 13C NMR δ 25.0, 48.5, 50.2, 
51.1, 62.4, 68.2, 127.2, 128.1, 128.30, 128.31, 128.4, 128.6, 128.7, 133.8, 135.0, 137.8, 
137.9, 175.7, 177.3, 200.7; IR (KBr) 3031, 2876, 1773, 1697, 1668, 1591, 1494, 1434, 
1381, 1323, 1284, 1230, 1115, 1069, 1001, 870, 755, 731, 697 cm–1; Found: C, 76.25; H, 
5.82; N, 6.57%; Calcd for C27H24N2O3: C, 76.39; H, 5.70; N, 6.60%. 
(3aR*,4R*,6R*,6aS*)-4-Benzoyl-2,5-dibenzyl-6-phenyltetrahydropyrrolo[3,4-c]pyrrole-
1,3(2H,3aH)-dione (6aB): Rf = 0.35 (hexane/Et2O = 1/1); a solid; m.p. 165–166 °C 
(from AcOEt/hexane); 1H NMR δ 3.28 (d, 1H, J = 7.8 Hz), 3.56 (d, 1H, J = 13.7 Hz), 
3.62 (dd, 1H, J = 9.6, 7.8 Hz), 3.67 (d, 1H, J = 13.7 Hz), 4.56 (d, 1H, J = 13.8 Hz), 4.65 
(d, 1H, J = 13.8 Hz), 5.11 (d, 1H, J = 9.6 Hz), 5.19 (s, 1H), 6.93–6.97 (m, 2H), 7.02–
7.12 (m, 2H), 7.13–7.27 (m, 6H), 7.37–7.46 (m, 7H), 7.55 (t, 1H, J = 7.3 Hz), 7.83 (d, 
2H, J = 7.8 Hz); 13C NMR δ 42.6, 48.0, 49.9, 50.5, 62.6, 68.0, 127.1, 127.8, 128.0, 
128.1, 128.3, 128.35, 128.40, 128.5, 128.7, 129.4, 133.7, 135.0, 135.8, 136.9, 138.0, 
175.0, 177.3, 200.3. IR (KBr) 3030, 2878, 1772, 1702, 1579, 1494, 1453, 1422, 1396, 
1339, 1235, 1175, 1136, 1027, 989, 727, 699 cm–1; Found: C, 79.25; H, 5.65; N, 5.63%; 
Calcd for C33H28N2O3: C, 79.18; H, 5.64; N, 5.60%. Crystal data: C33H28N2O3, Mr = 
500.60, monoclinic, P21/n, a = 11.7284(8), b = 9.1475(5), c = 24.016(2) Å, V = 
2528.7(3) Å3, β = 101.057(2)°, Z = 4, Dcalcd = 1.315 g cm–3, R = 0.065 (Rw = 0.070) for 
5599 reflections with I > 3.00σ(I) and 343 variable parameters. Crystallographic data 
for 6aB have been deposited with Cambridge Crystallographic Data Centre as 
supplementary publication No. CCDC 913503.  
(3aR*,4R*,6R*,6aS*)-2,5-Dibenzyl-4-heptanoyl-6-phenyltetrahydropyrrolo[3,4-
c]pyrrole-1,3(2H,3aH)-dione (6bB): Rf = 0.30 (hexane/AcOEt = 3/1); an oil; 1H NMR δ 
1.00–1.31 (m, 5H), 1.52–1.71 (m, 6H), 1.95–2.05 (m, 2H), 3.16 (d, 1H, J = 13.3 Hz), 
3.40–3.43 (m, 2H), 3.54 (d, 1H, J = 6.8 Hz), 3.70 (d, 1H, J = 13.3 Hz), 4.68 (d, 1H, J = 
13.7 Hz), 4.75 (d, 1H, J = 13.7 Hz), 4.85 (s, 1H), 6.86 (d, 2H, J = 6.8 Hz), 7.16–7.30 (m, 
6H), 7.35 (t, 2H, J = 7.3 Hz), 7.42–7.47 (m, 3H), 7.51 (d, 2H, J = 7.4 Hz); 13C NMR δ 
14,0, 22.4, 23.0, 28.7, 31.5, 42.1, 42.7, 47.2, 49.8, 51.0, 66.5, 68.1, 127.4, 127.9, 128.11, 
128.13, 128.50, 128.54, 128.6, 129.5, 135.8, 136.7, 138.0, 175.0, 177.1, 212.7; IR (neat) 
3063, 3032, 2929, 2857, 1775, 1713, 1604, 1585, 1495, 1454, 1433, 1398, 1347, 1290, 
1215, 1173, 1144, 1074, 1029, 921, 882, 832, 754, 699 cm–1; HRMS (FAB+) (M+ + H), 
Found: m/z 509.2808; Calcd for C33H37N2O3: 509.2804.  
(3aR*,4R*,6R*,6aS*)-2,5-Dibenzyl-4-phenyl-6-pivaloyltetrahydropyrrolo[3,4-
c]pyrrole-1,3(2H,3aH)-dione (6cB): Rf = 0.35 (hexane/Et2O = 1/1); a solid; m.p. 133–
134 °C (from AcOEt/hexane); 1H NMR δ 0.99 (s, 9H), 3.11 (d, 1H, J = 8.2 Hz), 3.37 (d, 
1H, J = 15.1 Hz), 3.55 (dd, 1H, J = 9.6, 8.2 Hz), 3.68 (d, 1H, J = 15.1 Hz), 4.55 (d, 1H, 
J = 13.7 Hz), 4.62 (d, 1H, J = 13.7 Hz), 4.83 (s, 1H), 5.27 (d, 1H, J = 9.6 Hz), 6.96–7.29 
(m, 10H), 7.35–7.41 (m, 3H), 7.43–7.46 (m, 2H); 13C NMR δ 26.0, 42.6, 44.9, 48.3, 
49.3, 50.4, 61.7, 68.4, 126.9, 127.2, 128.0, 128.1, 128.4, 128.5, 129.5, 135.8, 137.3, 
138.2, 175.0, 177.0, 217.8; IR (KBr) 3037, 2977, 1774, 1702, 1493, 1477, 1436, 1394, 
1343, 1215, 1172, 1136, 1062, 988, 878, 778, 753, 730, 701 cm–1; Found: C, 77.35; H, 
6.80; N, 5.79%; Calcd for C31H32N2O3: C, 77.47; H, 6.71; N, 5.83%.  
(3aR*,4R*,6S*,6aS*)-4-Benzoyl-2,5-dibenzyl-6-propyltetrahydropyrrolo[3,4-c]pyrrole-
1,3(2H,3aH)-dione (6dB): Rf = 0.30 (hexane/AcOEt = 4/1); a solid; m.p. 146–147 °C 
(from AcOEt/hexane); 1H NMR δ 0.93 (t, 3H, J = 6.9 Hz), 1.33–1.42 (m, 2H), 1.67–
1.81 (m, 2H), 3.25 (d, 1H, J = 7.8 Hz), 3.38 (t, 1H, J = 7.8 Hz), 3.71 (d, 1H, J = 14.2 
Hz), 3.87–3.96 (m, 1H), 3.94 (d, 1H, J = 14.2 Hz), 4.69 (d, 1H, J = 14.2 Hz), 4.76 (d, 
1H, J = 14.2 Hz), 4.88 (s, 1H), 6.92 (d, 2H, J = 6.0 Hz), 7.09–7.18 (m, 3H), 7.29–7.44 
(m, 7H), 7.52 (t, 1H, J = 7.3 Hz), 7.84 (d, 2H, J = 8.2 Hz); 13C NMR δ 14.4, 19.7, 31.8, 
42.6, 47.1, 47.4, 50.8, 63.6, 65.0, 127.0, 127.9, 128.0, 128.4, 128.5, 128.56, 128.64, 
128.7, 133.6, 134.9, 135.6, 138.8, 176.2, 177.8, 199.7; IR (KBr) 2960, 2869, 1772, 1702, 
1541, 1506, 1490, 1428, 1398, 1340, 1238, 1185, 1135, 1000, 724, 702 cm–1; Found: C, 
77.15; H, 6.62; N, 5.96%; Calcd for C30H30N2O3: C, 77.23; H, 6.48; N, 6.00%. 
(3aR*,4R*,6S*,6aS*)-4-Benzoyl-5-benzyl-6-cyclohexyl-2-methyltetrahydropyrrolo[3,4-
c]pyrrole-1,3(2H,3aH)-dione (6eA): Rf = 0.40 (hexane/Et2O = 1/1); a solid. m.p. 142–
143 °C (from AcOEt/hexane); 1H NMR δ 1.11–1.37 (m, 5H), 1.66–1.78 (m, 4H), 1.94–
2.04 (m, 1H), 2.08–2.15 (m, 1H), 3.04 (s, 3H), 3.41–3.53 (m, 4H), 3.85 (d, 1H, J = 13.3 
Hz), 4.97 (s, 1H), 7.10–7.14 (m, 2H), 7.21–7.27 (m, 5H), 7.43–7.49 (m, 3H); 13C NMR 
δ 25.3, 26.2, 26.4, 26.5, 29.5, 30.0, 36.1, 47.2, 47.3, 52.2, 65.4, 69.2, 127.5, 128.3, 
128.56, 128.65, 129.2, 133.1, 134.8, 137.8, 178.0, 179.0, 198.2. IR (KBr) 2922, 2851, 
1769, 1697, 1593, 1432, 1381, 1337, 1277, 1230, 1189, 1131, 1094, 1048, 752, 730, 
694 cm–1; Found: C, 75.26; H, 7.11; N, 6.53%; Calcd for C27H30N2O3: C, 75.32; H, 
7.02; N, 6.51%. Crystal data: C27H30N2O3, Mr = 430.55, monoclinic, P21/c, a = 
8.4348(7), b = 21.818(2), c = 12.635(1) Å, V = 2231.4(3) Å3, β = 106.338(2)°, Z = 4, 
Dcalcd = 1.281 g cm–3, R = 0.051 (Rw = 0.066) for 3690 reflections with I > 3.00σ(I) and 
289 variable parameters. Crystallographic data for 6eA have been deposited with 
Cambridge Crystallographic Data Centre as supplementary publication No. CCDC 
913504.  
 (3aR*,4R*,6S*,6aS*)-4-Benzoyl-2,5-benzyl-6-cyclohexyltetrahydropyrrolo[3,4-
c]pyrrole-1,3(2H,3aH)-dione (6eB): Rf = 0.40 (hexane/Et2O = 1/1); a solid; m.p. 161–
162 °C (from AcOEt/hexane); 1H NMR δ 1.01–1.31 (m, 5H), 1.62–1.71 (m, 4H), 1.88–
1.96 (m, 1H), 1.98–2.15 (m, 1H), 3.16 (d, 1H, J = 12.8 Hz), 3.39–3.43 (m, 2H), 3.52–
3.55 (m, 1H), 3.70 (d, 1H, J = 12.8 Hz), 4.68 (d, 1H, J = 13.8 Hz), 4.74 (d, 1H, J = 13.8 
Hz), 4.85 (s, 1H), 6.87 (d, 2H, J = 6.4 Hz), 7.16–7.31 (m, 6H), 7.33 (t, 2H, J = 7.8 Hz), 
7.41–7.48 (m, 1H), 7.46 (d, 2H, J = 7.3 Hz), 7.51 (d, 2H, J = 7.4 Hz); 13C NMR δ 26.2, 
26.3, 26.4, 29.6, 30.0, 36.0, 43.0, 47.2, 47.3, 51.8, 65.8, 69.2, 127.3, 128.2, 128.35, 
128.41, 128.6, 128.7, 129.0, 129.5, 133.1, 134.75, 134.83, 138.0, 177.4, 178.6, 197.9; 
IR (KBr) 3038, 2933, 2853, 1774, 1705, 1673, 1577, 1494, 1396, 1343, 1227, 1172, 
1142, 1073, 732, 704 cm–1; Found: C, 78.25; H, 6.78; N, 5.55%; Calcd for C33H34N2O3: 
C, 78.23; H, 6.76; N, 5.53%.  
(3aR*,4R*,6S*,6aS*)-2,5-Dibenzyl-4-heptanoyl-6-methyltetrahydropyrrolo[3,4-
c]pyrrole-1,3(2H,3aH)-dione (6fB): Rf = 0.35 (hexane/Et2O = 1/1); an oil; 1H NMR δ 
0.87 (t, 3H, J = 6.9 Hz), 1.14 (d, 3H, J = 6.4 Hz), 1.13–1.27 (m, 6H), 1.40–1.45 (m, 2H), 
2.15 (td, 1H, J = 7.4, 17.4 Hz), 2.30 (td, 1H, J = 7.8, 17.4 Hz), 3.04 (d, 1H, J = 7.8 Hz), 
3.24 (t, 1H, J = 7.8 Hz), 3.58 (d, 1H, J = 13.8 Hz), 3.82–3.89 (m, 1H), 3.84 (d, 1H, J = 
13.8 Hz), 3.98 (s, 1H), 4.67 (d, 1H, J = 14.2 Hz), 4.72 (d, 1H, J = 14.2 Hz), 7.00–7.02 
(m, 2H), 7.18–7.42 (m, 8H); 13C NMR δ 14.0, 15.7, 22.3, 23.1, 28.7, 31.4, 41.4, 42.5, 
46.5, 48.1, 50.8, 57.9, 68.2, 127.2, 127.9, 128.0, 128.39, 128.41, 128.5, 135.6, 138.4, 
176.2, 177.5, 211.9; IR (neat) 3038, 2929, 2857, 1774, 1708, 1496, 1455, 1432, 1397, 
1345, 1178, 1078, 732, 700 cm–1; HRMS (FAB+) (M+ + H), Found: m/z 447.2640; 
Calcd for C28H35N2O3 : 447.2648.   
1,3-Dipolar cycloaddition of azomethine ylide generated from trans-isomer of 3c: A 
mixture of trans-isomer of 3c (26 mg, 0.09 mmol) and N-benzylmaleimide (5B) (20 mg, 
0.11 mmol) in xylene (0.9 mL) was heated at 145 °C for 1.5 h and cooled to rt. The 
solvent was removed under reduced pressure. The residue was purified by preparative 
TLC (hexane/AcOEt = 5/1) to give 6cB (36 mg, 84% yield).  
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(2 steps, one pot)  
 Yoshiaki Miyamoto, Norihiro 
Wada, Takahiro Soeta, Katsuhiko 
Inomata, and Yutaka Ukaji* 
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One-pot Stereoselective Syntheses 
of 2-Acylaziridines and 2-
Acylpyrrolidines from N-
(Propargylic)hydroxylamines 
 A stereoselective direct 
transformation of N-
(propargylic)hydroxylamines into 
cis-2-acylaziridines was realized by 
the combined use of AgBF4 and 
CuCl. The subsequent 1,3-dipolar 
cycloaddition of azomethine ylides 
generated in situ from the 
intermediary 2-acylaziridines with 
maleimides was achieved by one-pot 
procedure to afford the 
corresponding 2-acylpyrrolidines 
consisting of an 
octahydropyrrolo[3,4-c]pyrrole 
skeleton stereoselectively. 
 
 
 
 
